BMC Surgery | |
Total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation as the treatment of choice for secondary hyperparathyroidism: a single-center experience | |
Lei Cao1  Zhen Lv1  Yanming Ge2  Yanning Li1  Songjian Duan1  Jian Zhu1  Peng Zhou1  Ziyi Fan1  Luming Zheng1  Dayong Zhuang1  Qingqing He1  | |
[1] Department of Thyroid and Breast Surgery, Jinan Military General Hospital of PLA, No.25 Shifan Road, Jinan 250031, People's Republic of China;Blood Purification Center, Jinan Military General Hospital of PLA, Jinan 250031, People's Republic of China | |
关键词: Autotransplantation; Parathyroid hormone; Total parathyroidectomy; Chronic renal failure; Secondary hyperparathyroidism; | |
Others : 866846 DOI : 10.1186/1471-2482-14-26 |
|
received in 2013-04-27, accepted in 2014-04-25, 发布年份 2014 | |
【 摘 要 】
Background
The aim of the study was to evaluate total parathyroidectomy with trace amounts of parathyroid tissue (30 mg) as a surgical option in secondary hyperparathyroidism (sHPT) treatment.
Methods
From January 2008 to March 2012, 47 patients underwent parathyroidectomy. Comparisons of demographic data, symptoms, and preoperative or postoperative biochemistry were made between total parathyroidectomy with trace amounts of parathyroid tissue autotransplantation group and total parathyroidectomy group.
Results
Out of 47 cases, 45 had successful operation. 187 parathyroid glands identified at the initial operation were reported in 47 patients. 43 patients had been diagnosed with parathyroid hyperplasia, and 4 patients had a benign adenoma. After operation, pruritus, bone pain and muscle weakness disappeared, also serum PTH and serum phosphate were declined markedly as well. After discharge, two patients (in total parathyroidectomy group) were readmitted because of postoperative hypoparathyroidism. Graft-dependent recurrence was not observed in an average follow-up of 42 months.
Conclusions
Total parathyroidectomy with sternocleidomastoid muscle trace amounts of parathyroid tissue autotransplantation is considered to be a feasible, safe and effective surgical option for the patients with sHPT.
【 授权许可】
2014 He et al.; licensee BioMed Central Ltd.
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
20140728041918865.pdf | 944KB | download | |
55KB | Image | download | |
76KB | Image | download | |
68KB | Image | download | |
68KB | Image | download |
【 图 表 】
【 参考文献 】
- [1]Schneider R, Kolios G, Koch BM, Fernández ED, Bartsch DK, Schlosser K: An economic comparison of surgical and medical therapy in patients with secondary hyperparathyroidism–the German perspective. Surgery 2010, 148(6):1091-1099.
- [2]Iannazzo S, Carsi M, Chiroli S: A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries. Appl Health Econ Health Policy 2012, 10(2):127-138.
- [3]Shen WT, Kebebew E, Suh I, Duh QY, Clark OH: Two hundred and two consecutive operations for secondary hyperparathyroidism: has medical management changed the profiles of patients requiring parathyroidectomy? Surgery 2009, 146(2):296-299.
- [4]Conzo G, Perna AF, Savica V, Palazzo A, Della Pietra C, Ingrosso D, Satta E, Capasso G, Santini L, Docimo G: Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era. BMC Surg 2013, 13(Suppl 2):S4. doi:10.1186/1471-2482-13-S2-S4 BioMed Central Full Text
- [5]Kovacevic B, Ignjatovic M, Zivaljevic V, Cuk V, Scepanovic M, Petrovic Z, Paunovic I: Parathyroidectomy for the attainment of NKF-K/DOQI™ and KDIGO recommended values for bone and mineral metabolism in dialysis patients with uncontrollable secondary hyperparathyroidism. Langenbecks Arch Surg 2012, 397(3):413-420.
- [6]Naranda J, Ekart R, Pečovnik-Balon B: Total parathyroidectomy with forearm autotransplantation as the treatment of choice for secondary hyperparathyroidism. J Int Med Res 2011, 39(3):978-987.
- [7]Schneider R, Slater EP, Karakas E, Bartsch DK, Schlosser K: Initial parathyroid surgery in 606 patients with renal hyperparathyroidism. World J Surg 2012, 36(2):318-326.
- [8]Sharma J, Raggi P, Kutner N, Bailey J, Zhang R, Huang Y, Herzog CA, Weber C: Improved long-term survival of dialysis patients after near-total parathyroidectomy. J Am Coll Surg 2012, 214(4):400-408.
- [9]Conzo G, Perna AF, Sinisi AA, Palazzo A, Stanzione F, Della Pietra C, Livrea A: Total parathyroidectomy without autotransplantation in the surgical treatment of secondary hyperparathyroidism of chronic kidney disease. J Endocrinol Invest 2012, 35(1):8-13.
- [10]Madorin C, Owen RP, Fraser WD, Pellitteri PK, Radbill B, Rinaldo A, Seethala RR, Shaha AR, Silver CE, Suh MY, Weinstein B, Ferlito A: The surgical management of renal hyperparathyroidism. Eur Arch Otorhinolaryngol 2012, 269(6):1565-1576.
- [11]Schneider R, Waldmann J, Ramaswamy A, Fernández ED, Bartsch DK, Schlosser K: Frequency of ectopic and supernumerary intrathymic parathyroid glands in patients with renal hyperparathyroidism: analysis of 461 patients undergoing initial parathyroidectomy with bilateral cervical thymectomy. World J Surg 2011, 35(6):1260-1265.
- [12]Uludag M, Yetkin G, Citgez B, Ozguven BY, Cengiz AN, Ozsahin H, Isgor A: The role of cervical thymectomy in surgical treatment of secondary hyperparathyroidism. Bratisl Lek Listy 2011, 112(7):385-389.
- [13]Yuan CM, Nee R, Narayan R, Abbott KC: Treatment of secondary hyperparathyroidism with parathyroidectomy instead of cinacalcet: time to pick the low-hanging fruit ? Am J Kidney Dis 2012, 60(2):179-181.
- [14]Alesina PF, Hinrichs J, Kribben A, Walz MK: Minimally invasive video-assisted parathyroidectomy (MIVAP) for secondary hyperparathyroidism: report of initial experience. Am J Surg 2010, 199(6):851-855.
- [15]Drakopoulos S, Koukoulaki M, Apostolou T, Pistolas D, Balaska K, Gavriil S, Hadjiconstantinou V: Total parathyroidectomy without autotransplantation in dialysis patients and renal transplant recipients, long-term follow-up evaluation. Am J Surg 2009, 198(2):178-183.
- [16]Iwamoto N, Sato N, Nishida M, Hashimoto T, Kobayashi H, Yamasaki S, Ono T, Nishimura M, Tokoro T, Sakoda C, Murakawa M, Okino K, Okamoto Y, Imai R, Adachi N, Ninomiya K, Mabuchi H, Koyama M, Nakanouchi T, Iseki K: Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism. J Nephrol 2012, 25(5):755-763.
- [17]Sanbury SW, Lumb GA, Nicholson WF: Elective subtotal parathyroidectomy for renal hyperparathyroidism. Lancet 1960, 1(7128):793-799.
- [18]Wells SA Jr, Gunnells JC, Shelburne JD, Schneider AB, Sherwood LM: Transplantation of the parathyroid glands in man: clinical indications and results. Surgery 1975, 78(1):34-44.
- [19]Tominaga Y, Matsuoka S, Uno N, Tsuzuki T, Hiramitsu T, Goto N, Nagasaka T, Watarai Y, Uchida K: Removal of autografted parathyroid tissue for recurrent renal hyperparathyroidism in hemodialysis patients. World J Surg 2010, 34(6):1312-1317.
- [20]Ogg CS: Total parathyroidectomy in treatment of secondary (renal) hyperparathyroidism. Br Med J 1967, 4(5575):331-334.
- [21]Goldfarb M, Gondek SS, Lim SM, Farra JC, Nose V, Lew JI: Postoperative hungry bone syndrome in patients with secondary hyperparathyroidism of renal origin. World J Surg 2012, 36(6):1314-1319.
- [22]Chan HW, Chu KH, Fung SK, Tang HL, Lee W, Cheuk A, Yim KF, Tong MK, Lee KC: Prospective study on dialysis patients after total parathyroidectomy without autoimplant. Nephrology (Carlton) 2010, 15(4):441-447.
- [23]Yan H, Sharma J, Weber CJ, Guyton RA, Perez S, Thourani VH: Elevated parathyroid hormone predicts mortality in dialysis patients undergoing valve surgery. Surgery 2011, 150(6):1095-1101.
- [24]Kim WY, Lee JB, Kim HY: Efficacy of intraoperative parathyroid hormone monitoring to predict success of parathyroidectomy for secondary hyperparathyroidism. J Korean Surg Soc 2012, 83(1):1-6.
- [25]Puccini M, Carpi A, Cupisti A, Caprioli R, Iacconi P, Barsotti M, Buccianti P, Mechanick J, Nicolini A, Miccoli P: Total parathyroidectomy without autotransplantation for the treatment of secondary hyperparathyroidism associated with chronic kidney disease: clinical and laboratory long-term follow-up. Biomed Pharmacother 2010, 64(5):359-362.
- [26]Agha A, Loss M, Schlitt HJ, Scherer MN: Recurrence of secondary hyperparathyroidism in patients after total parathyroidectomy with autotransplantation: technical and therapeutic aspects. Eur Arch Otorhinolaryngol 2012, 269(5):1519-1525.
- [27]Conzo G, Perna A, Candela G, Palazzo A, Parmeggiani D, Napolitano S, Esposito D, Cavallo F, Docimo G, Santini L: Long-term outcomes following "presumed" total parathyroidectomy for secondary hyperparathyroidism of chronic kidney disease. G Chir 2012, 33(11–12):379-382.